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Abstract
Background: A variety of approaches to understanding protein structure and function require
production of recombinant protein. Mammalian based expression systems have advantages over
bacterial systems for certain classes of protein but can be slower and more laborious. Thus the
availability of a simple system for production and rapid screening of constructs or conditions for
mammalian expression would be of great benefit. To this end we have coupled an efficient
recombinant protein production system based on transient transfection in HEK-293 EBNA1 (HEK-
293E) suspension cells with a dot blot method allowing pre-screening of proteins expressed in cells
in a high throughput manner.
Results: A nested PCR approach was used to clone 21 extracellular domains of mouse receptors
as CD4 fusions within a mammalian GATEWAY expression vector system. Following transient
transfection, HEK-293E cells grown in 2 ml cultures in 24-deep well blocks showed similar growth
kinetics, viability and recombinant protein expression profiles, to those grown in 50 ml shake flask
cultures as judged by western blotting. Following optimisation, fluorescent dot blot analysis of
transfection supernatants was shown to be a rapid method for analysing protein expression yielding
similar results as western blot analysis. Addition of urea enhanced the binding of glycoproteins to
a nitrocellulose membrane. A good correlation was observed between the results of a plate based
small scale transient transfection dot blot pre-screen and successful purification of proteins
expressed at the 50 ml scale.
Conclusion: The combination of small scale multi-well plate culture and dot blotting described
here will allow the multiplex analysis of different mammalian expression experiments enabling a
faster identification of high yield expression constructs or conditions prior to large scale protein
production. The methods for parallel GATEWAY cloning and expression of multiple constructs in
cell culture will also be useful for applications such as the generation of receptor protein
microarrays.
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Background
Functional genomic applications have increased the
requirement for producing large protein sets including the
generation of protein microarrays for mapping protein-
protein, nucleic acid or small molecule interactions [1,2],
high throughput antibody generation [3,4] and structural
genomics [5]. Although expression of recombinant pro-
teins in bacteria is widely used, mammalian expression
systems have advantages for the production of mamma-
lian proteins, allowing correct folding or authentic post-
translational modifications. The use of transient expres-
sion systems rather than stable expression systems has
facilitated the rapid production of cells producing pro-
teins of interest. There are in fact many examples where
large scale transient transfection of HEK-293E cells have
successfully been used to produce proteins [6-10]. In our
laboratory, 50 – 200 ml transient transfections of HEK-
293E cells routinely provide 10–1000's µg amounts of
secreted protein fragments of receptor extracellular (EC)
domains (unpublished). A proportion of attempted tran-
sient transfections however result in the absence of
secreted protein. The ability to pre-screen multiple expres-
sion vectors for secreted protein production on a small
scale and thus identify failures prior to the larger scale
transfections would reduce time, cost of reagents and
allow an increased number of proteins to be produced at
the large scale. The method would also allow the rapid
screening of different expression conditions to optimise
expression including media formulation, co-expression of
chaperones [11], anti-apoptotic proteins [12] or binding
partners [13]. The effect of fusion partners, signal peptide
sequences or truncations could also be rapidly assessed.
This is particularly important during the identification of
stable cell lines yielding high levels of therapeutic anti-
bodies or proteins.
The use of suspension cells rather than adherent cells
[8,9,14,15] for a transient transfection pre-screen reduces
the time required to perform the pre-screen and lends
itself to direct comparison of subsequent suspension cell
growth in the 50 – 200 ml shake flask cultures. The advan-
tage of 24 well blocks for transient transfections is that
this allows the multiple processing of expression vectors
facilitating the rapid detection of expression failures. The
aim of this work was to devise and implement a system for
pre-screening expression vectors for positive hits prior to
large scale protein production work. Here we show that
small scale transient transfection of mammalian suspen-
sion cells together with analysis by dot blot can be used to
assess positive expression hits in a multiparallel high
throughput manner.
Results
Vector construction
GATEWAY cloning technology (Invitrogen) was chosen
for the generation of expression vectors making it possible
to rapidly generate vectors containing the same coding
sequence with different vector backbone options (for
example N or C-terminal tags, different expression vector
cassettes). 26 proteins representing the extracellular
domains of receptors (including four proteins used as
controls, rCD4, mCD4, mCD200-rCD4 and EfnB2, previ-
ously shown to express well in the HEK-293E transient
transfection system (data not shown)) were chosen for
this small scale transient transfection pre-screen (Table 1).
All are mouse proteins with the exception of the rat CD4
control protein (rCD4). All vectors with the exception of
the three control proteins contained a C-terminal rCD4
(domains 3 + 4)-His10 tag. Brown and Barclay, 1994 [16]
have previously shown that fusion of the extracellular
domains of receptors to rCD4 (domains 3 + 4) can both
enhance their expression and produce the proteins in a
monomeric form suitable for kinetic and affinity analysis.
Secretion of the tagged test proteins into the culture super-
natant was driven by the native signal peptide. The list
includes proteins with different numbers of Ig domains
(between 1–4) and N-glycosylation sites (between 0–8).
The genes were isolated from cDNA libraries and cloned
into destination vectors (Figure 1) using GATEWAY
recombinational cloning (this cloning method has been
previously described by Hartley et al., 2000 [17]). The des-
tination vector used in this study was constructed by mod-
ifying the pTT3 vector [7]. The pTT3 vector backbone
features the Epstein-Barr virus (EBV) oriP allowing episo-
mal replication of the plasmid within transfected cells and
an improved human cytomegalovirus (CMV) expression
cassette containing an intron downstream from the pro-
moter serving to enhance expression [7]. Figure 1 shows
schematic of expression vector constructs for both test and
control vectors (see Methods).
Growth kinetics of HEK-293E cells in 24 deep well blocks
To identify the seeding densities allowing survival and
growth of HEK-293E cells in 24 well blocks (Qiagen), cells
were seeded at 2.5 × 105, 5 × 105 or 1 × 106 cells/ml in a 4
ml culture volume. The highest viability and consistent
logarithmic growth was identified at seeding densities of
5 × 105 and 1 × 106 cells/ml, which produced very similar
growth kinetics. Cells seeded at 2.5 × 105 cells/ml showed
low growth and poor viability from 24 hours post seeding
(data not shown). The rotation speed at which the cells
were grown was found to be optimal at 400 rpm (orbital
throw 3 mm) and cells did not stay in suspension when
speeds of 250 – 350 rpm were tested (data not shown).
The addition of 0.1 % pluronic, a non-ionic detergent,
allowed cells to continue to grow beyond 48 hours postBMC Biotechnology 2006, 6:49 http://www.biomedcentral.com/1472-6750/6/49
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seeding, presumably due to a reduction in shear stress
(data not shown).
The use of smaller volumes reduces both the number of
cells in culture and the amount of DNA required for their
transient transfection. Two culture volumes were tested, 2
ml and 4 ml, with cells seeded at 5 × 105 cells/ml in both.
Cell counts and cell viability were monitored from dupli-
cate wells every 24 hours over a 96 hour period. We ana-
lysed samples in triplicate using trypan blue exclusion dye
to assess cell viability. Cell growth and viability in 2 ml
culture volume closely matched that of the 4 ml culture
volume Figure 2). Cell viability remained above 97 % in
both culture volumes (Figure 2 line graph), cells doubled
approximately every 24 hours in both culture volumes
(Figure 2 bar chart). All subsequent work was done using
the 2 ml culture volume.
Comparison of growth kinetics of HEK-293E cells grown in 
block culture and 50 ml shake culture
The growth kinetics of cells grown in 2 ml culture volume
in 24 well blocks with cells grown in 50 ml shake culture
was compared. Our standard seeding density for HEK-
293E cells in 50 ml shake culture is 1 × 106 cells/ml. To
maintain consistency, cells were seeded at 1 × 106 cells/ml
in both 2 ml and 50 ml culture volumes and measured cell
growth and viability every 24 hours for 96 hours. Samples
were analysed in triplicate using trypan blue exclusion dye
to assess cell viability. Cell growth characteristics in both
the 24 well blocks and shake flask cultures were very sim-
ilar at all time points analysed (Figure 3). In both the 2 ml
24 well blocks and 50 ml shake culture, from 72 hours
post seeding (hps) living cells began to aggregate, making
accurate counting more difficult and causing the measure-
ments to vary more than at other time points. By 96 hps,
cells, including aggregated cells, are beginning to die and
become stained with trypan blue dye. Stained cells are not
included in cell growth calculations which results in
smaller standard deviations between counts. The reduc-
tion in total culture volume does not have an effect on cell
growth and viability. In figures 2 and 3 it is clear that
when cell culture density reaches approximately 1 × 107
cells/ml the cell viability starts to decrease. This is
observed after 72 hrs (Figure 3) and after 96 hrs (Figure 2)
due to the difference between initial seeding densities.
Equivalent protein expression in small or large scale 
culture
Twenty three different expression vectors were tested for
secreted protein production following transient transfec-
Table 1: Expression vectors used in study
Vector Gene name Ensemble ID C-tag Mwt (kDa)
#1 Mfap3 ENSMUSP00000020830 rCD4-His10 36.99
#2 CLM9 ENSMUSP00000017453 rCD4-His10 39.97
#3 Undefined ENSMUSP00000024791 rCD4-His10 33.43
#4 4732429D16Rik ENSMUSP00000047022 rCD4-His10 41.51
#5 BC025105 ENSMUSP00000051521 rCD4-His10 42.77
#6 Fcer1a ENSMUSP00000056882 rCD4-His10 44.67
#7 Cd2 ENSMUSP00000029456 rCD4-His10 45.15
#8 Tmem251 ENSMUSP00000002100 rCD4-His10 47.03
#9 Tmem251 ENSMUSP00000002100 rCD4-His10 47.03
#10 Tmem252 ENSMUSP00000002100 rCD4-His10 47.03
#11 F11r ENSMUSP00000041907 rCD4-His10 47.44
#12 Ptpns1 ENSMUSP00000049022 rCD4-His10 62.61
#13 Il18rap ENSMUSP00000027237 rCD4-His10 63.21
#14 Unc5b ENSMUSP00000077080 rCD4-His10 63.45
#15 Fgfrl1 ENSMUSP00000013633 rCD4-His10 62.41
#16 AI415330 ENSMUSP00000059913 rCD4-His10 66.44
#17 Ly9 ENSMUSP00000069319 rCD4-His10 72.27
#18 Scn3b ENSMUSP00000051627 rCD4-His10 46.60
#19 E130306I01Rik ENSMUSP00000061906 rCD4-His10 65.66
#20 Kit ENSMUSP00000005815 rCD4-His10 94.62
#21 Lag3 ENSMUSP00000032217 rCD4-His10 69.63
#22 Lrrn1 ENSMUSP00000037096 rCD4-His10 92.52
Control rCD4 CD4 ENSRNOP00000021915 His10 24.20
Control EfnB2 EfnB2 ENSMUSP00000001319 His8 23.29
Control mCD4 CD4 ENSMUSP00000024044 His10 26.30
Control mCD200 CD200 ENSMUSP00000023341 rCD4-His10 46.57
Expression vectors (#1 – #22) encoding the extra-cellular region of mouse receptor genes used for deep well block transient expression study. 
Tmem251 contained a frameshift mutation and Tmem252 contained no mutations relative to the reference sequence. Included in this table are the 
four control vectors rat CD4 (domains 3 + 4), mouse EfnB2 (extra-cellular region), mouse CD4 (domains 3 + 4) and mouse CD200 (extra-cellular 
region).BMC Biotechnology 2006, 6:49 http://www.biomedcentral.com/1472-6750/6/49
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tion of HEK-293E cells either in large (50 ml) or small (2
ml) scale cultures. 50 ml culture volumes were seeded at 1
× 106 cells/ml and transfection supernatants were har-
vested at 120 hours post transfection (hpt) and analysed
by fluorescent Cy5 western blot (Figure 4A). Supernatants
showed 13 secretion positive vectors (#2, 3, 6, 7, 10, 11,
13, 14, 16, 17, 21, 22 and C) and 10 secretion negative
vectors (#1, 4, 5, 8, 9, 12, 15, 18, 19 and 20). Failure to
secrete is unlikely to be caused by expression from a
GATEWAY vector, which requires the translation of the
attB2 linker (NPAFLYKVV) as shown in Figure 1, because
a comparison of a GATEWAY and non-GATEWAY expres-
sion vector showed similar levels of expression for Cd200
EC domain fused to rCD4 (domains 3 + 4) (data not
shown). It is more likely that failure to secrete is due to a
property of the protein to be expressed and reasons could
include RNA instability, RNA secondary structure result-
ing in reduced translation levels, inefficient native signal
peptides, susceptibility to proteolysis or the requirement
of heterodimerisation for stability and secretion. The
highest signal intensity was observed for vector #3 and the
weakest positive signal intensity for vector #5 (Table 2).
Small scale transfections were performed using two differ-
ent seeding densities (5 × 105 or 1 × 106 cells/ml) since
both these densities gave good growth kinetics in the 2 ml
culture volume. Transfection supernatants were harvested
at 120 hpt and analysed by western blot as above. The
highest levels of secreted protein were observed when the
higher seeding density was used (Figure 4B). Both western
blot and signal intensity data confirmed an identical pat-
tern of expression in 2 ml and 50 ml culture volumes, the
same vectors were positive and negative for secreted pro-
tein in both and the most highly expressed protein (#3)
was also the same (Table 2). In most cases supernatants
Expression vector constructs used in transient transfections and purified protein controls Figure 1
Expression vector constructs used in transient transfections and purified protein controls. (A) Schematic repre-
sentation of His10 and His 8 tagged expression vectors with amino acid sequence of attB2 site and His tag shown. (B) Sche-
matic representation of rCD4(d3+4)-His10 tagged expression vector used to express mouse test proteins, amino acid 
sequence from attB2 site to stop codon (rCD4 sequence has been represented as rCD4) is shown. (C) Schematic representa-
tion of His10 tagged expression vector containing signal peptide (SP) at N terminus with amino acid sequence of SP and attB1 
site shown. CMV = CMV promoter element, ORF = open reading frame, attB1 = attB1 recombination site, attB2 = attB2 
recombination site, rCD4 = rat CD4 domains 3 and 4 tag, His10 = decahistidine tag, His8 = octahistidine tag, stop = stop 
codon and SP = CD33 signal peptide sequence.
ORF
B
attB2 His10/
His8
stop
SfiI EcoRV
ORF-NPAFLYKVVRWGPEWPISHHHHHHHHHH**/
C CMV ORF attB2 His10 stop
SfiI EcoRV
SP attB1
A
MPLLLLLPLLWAGALAMDQNKLRIPHQTSLYKKAGS-ORF
HindIII BamHI
CMV attB1
ORF-NPAFLYKVVRWGPEWPISHHHHHHHH**
CMV attB2 His10 stop
DraIII/SfiI fusion EcoRV
ORF-NPAFLYKVVR-rCD4-QVLSKGLNGPEWPISHHHHHHHHHH**
rCD4d3/4 ORF
SfiI
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from both transfection culture volumes showed varying
amounts of cleaved rCD4 tag at approx 30 kDa. Cleavage
was previously observed for expression of a T cell receptor
V domain – rCD4 (domains 3 + 4) fusion [16]. The varia-
ble levels of cleavage observed in Figure 4, between differ-
ent receptors, suggest that cleavage is occurring at the C-
terminus of the target receptors rather than within the
constant attB2 linker – rCD4 polypeptide. Most proteins
display a higher observed molecular weight compared
with the calculated molecular weight in Table 1 due to gly-
cosylation. In addition, some protein bands appear dif-
fuse. When similar proteins produced in this HEK-293E
system are deglycosylated they run as sharper bands on a
western blot (data not shown).
Dot blot conditions
Western blot analysis provides essential information
about the successful expression of secreted protein but
does not lend itself to high-throughput analysis. In order
to analyse multiple samples in parallel we investigated the
use of the dot blot method to provide much of the same
information as western blotting. This involved immobilis-
ing proteins onto a nitrocellulose membrane and probing
with mouse anti-His-tag and anti-mouse Cy5 labelled
antibodies (see Methods). Prior to analysing samples by
the dot blot method, various conditions for dotting sam-
ples onto nitrocellulose membrane were tested to achieve
the best signal. Previous attempts with supernatants and
purified protein under native conditions gave uneven
binding (data not shown). A purified control protein,
EfnB2, diluted in mock supernatant was analysed under
native conditions and in varying concentrations (6 M to 2
M) of urea to promote denaturation (Figure 5A). A total of
2.4 µg of protein was loaded per dot and all conditions
were analysed in triplicate. The intensity of each dot,
measured using ImageQuant software, is represented as a
Comparison of HEK-293E cell growth in different volumes within a 24 well block Figure 2
Comparison of HEK-293E cell growth in different volumes within a 24 well block. Cells were seeded at 0.5 × 106 
cells/ml in either 2 ml or 4 ml. Cells were analysed in duplicate and counted using a Neubauer haemocytometer to calculate 
cell growth and viability.
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bar chart (Figure 5B). Immobilisation in 2 M urea showed
similar levels to the native conditions. The highest signal
was observed using 5 M urea and this was chosen as the
condition for future dot blot analysis of purified protein
and supernatants.
Dot Blot calibration curves
In order to validate the use of dot intensity to quantitate
the amount of expressed protein, calibration curves were
made using three purified control proteins, EfnB2(EC)-
His8, mCD4(d3 + 4)-His10 and mCD200-rCD4(d3+4)-
His10. Proteins were diluted in mock supernatant and
urea was added to a final concentration of 5 M. The
amount of protein loaded per dot varied from 0–3000 ng
and all samples were analysed in triplicate (Figure 6). The
intensity of each dot was measured using ImageQuant
software and calibration curves plotted. Signal intensity at
a given amount of protein varied, suggesting that some
proteins bind to the membrane at different efficiencies
but each individual protein showed a linear relationship
between dot signal intensity and amount of protein per
dot over the range of 7.5 ng to 3 µg (25 ng/ml to 10 µg/
ml) for EfnB2(EC)-His8 and 75 ng to 3 µg (250 ng/ml to
10  µg/ml) for mCD4(d3+4)-His10 and mCD200-
rCD4(d3+4)-His10. Fluorescence detection, despite being
10-fold less sensitive compared to chemiluminscence,
gave a superior linear dynamic range [18,19].
Analysis of the 2 ml transfection supernatants by dot blot
Supernatants from the small scale transfections were ana-
lysed by fluorescent Cy5 dot blot. Supernatants were
diluted in urea to a final concentration of 5 M prior to
loading onto the membrane. In Figure 7, the top half of
the membrane shows the supernatants from the lower
seeding density cultures and the bottom half shows super-
natants from the higher seeding density cultures. As with
the western blots (Figure 4B) the higher seeding density
resulted in signals higher than those seen with the lower
seeding density. The dots from the bottom half of the
membrane showing a positive signal were analysed using
ImageQuant software. There were 14 vectors that showed
secreted protein that was detectable by dot blot (2, 3, 6, 7,
Comparison of HEK-293E growth kinetics in 24 well blocks culture and 50 ml flask culture Figure 3
Comparison of HEK-293E growth kinetics in 24 well blocks culture and 50 ml flask culture. Cells were seeded at 1 
× 106 cells/ml in either a total of 50 ml (flask) or 2 ml (24 well blocks). Two separate 24 well blocks were analysed alongside 
one large scale flask culture in triplicate. Cells were counted using a Neubauer haemocytometer to calculate cell growth and 
cell viability. Error bars represent standard deviations calculated from the data (n = 3).
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10, 11, 13, 14, 16, 17, 19, 21, 22 and C) and 9 vectors that
showed no detectable secreted protein expression (1, 4, 5,
8, 9, 12, 15, 18 and 20). Again, vector #3 showed the high-
est signal intensity, however, the lowest intensity from a
secretion positive vector was observed for vector #19
(Table 2).
Dot blot screen correlates with purified protein yield
The supernatants from the 50 ml culture supernatants
were purified by immobilised metal affinity chromatogra-
phy (IMAC) followed by a desalt step over a sephadex col-
umn and cation exchange chromatography to concentrate
the protein (see Methods section). The yield of purified
product was estimated from the area under the observed
280 nm absorbance peak during the sephadex column
step and this was converted to the protein yield in µg
using the calculated extinction coefficient for each protein
[20]. The calculated yield values are contained in the
penultimate column headed "Ex-IMAC AKTA" in Table 2.
It was found that the protein yields calculated here were
usually over-estimates possibly due to some residual imi-
dazole buffer contributing to the 280 nm absorbance, the
shoulder absorbance of the bicine buffer or the presence
of protein aggregates. Selected purified proteins were also
spun to remove aggregates, analysed by analytical size
exclusion chromatography (SEC) (see Methods section)
and the calculated yields are shown in the last column
headed "analytical SEC" in Table 2. Single peak integra-
tion was linear in the range of 40 – 700 ng using maltose
binding protein (MBP) and bovine IgG as standards (data
not shown). The proteins that showed the highest inten-
sity of signal by dot blot (Figure 7, vectors #17, 21, 2, 6,
14, 3, 7 and control) went on to be successfully purified
from the large scale culture (with the exception of the
product of vector #16) showing the good predictive value
of this system. Vectors #11 and 19 were failures when ana-
lysed by western blot (Figure 4) but showed a weak posi-
tive hit by dot blot (Table 2). Vectors that showed a small
visible peak of protein when run on the AKTA showed a
lower intensity on the dot blot. These weakly positive vec-
Table 2: Expression analysis of proteins.
Fluorescence Intensity (×104)
50 ml culture 2 ml culture
Vector Protein Western blot Dot blot Ex-IMAC AKTA (µg) Analytical SEC (µg)
#1 Mfap3 0 0 0.4 0 -
#2 CLM9 850.6 657.1 298.4 535.5 124.6
#3 Undefined 1228.5 1054.3 1516.6 833.1 526.0
#4 4732429D16Rik 0 0 15.8 0 -
#5 BC025105 19.6 56.3 9.7 0 -
#6 Fcer1a 795.9 456.0 909.6 256.0 97.8
#7 Cd2 900.6 584.5 432.2 483.1 387.2
#8 Tmem25 0 0 5.6 0 -
#9 Tmem25 0 0 6.8 0 -
#10 Tmem25 53.6 122.3 147.5 117.9 -
#11 F11r 0 0 44.4 79.3 -
#12 Ptpns1 0 0 0.2 0 -
#13 Il18rap 65.4 65.3 152.0 70.3 -
#14 Unc5b 419.7 101.9 206.0 297.3 68.6
#15 Fgfrl1 0 0 5.0 64.6 -
#16 AI415330 312.1 58.3 1081.3 191.2 -
#17 Ly9 494.6 425.5 485.9 387.5 57.6
#18 Scn3b 0 0 5.6 0 -
#19 E130306I01Rik 0 0 25.3 0 -
#20 Kit 0 0 4.2 0 -
#21 Lag3 410.7 428.6 371.1 296.8 73.1
#22 Lrrn1 182.6 90.4 117.4 131.3 -
Fluorescent intensity of bands on western blot and dots on dot blots were analysed using ImageQuant software. The Ex-IMAC AKTA column 
values are calculated by integrating the elution peak from the sephadex column between the IMAC and ion-exchange steps. The Analytical SEC 
column values are calculated by analysing the purified proteins (see Methods section). There is a cut off during AKTA purification, if the imidazole 
strip peak detects < 200 ug the fraction is not collected and therefore no protein is purified and there is nothing to analyse on the SEC. All values 
are normalised to the same input volume of 50 ml for western blot, dot blot and purification analysis. Abbreviations: IMAC (Immobilised Metal 
Affinity Chromatography), SEC (Size Exclusion Chromatograpy).BMC Biotechnology 2006, 6:49 http://www.biomedcentral.com/1472-6750/6/49
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Protein expression in 24 well blocks and 50 ml flask culture Figure 4
Protein expression in 24 well blocks and 50 ml flask culture. Supernatants from 50 ml shake flask (A) and 2 ml 24 well 
block (B) transient transfections were analysed by Cy5 western blot. The 13 vectors which are positive for protein production 
are indicated by arrows. In B, the two different seeding density samples from the 24 well blocks were run adjacent to each 
other with the lower seeding density sample loaded first. The control protein C was rCD4 (domains 3 + 4)-His10 expressed 
from vector C, Figure 1.
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tors (vector #13, 10, 11, 22, and 16) are good candidates
for larger scale (>50 ml) transient transfections to produce
increased amounts of protein.
Discussion
A number of expression systems can be used for the pro-
duction of recombinant proteins. Mammalian expression
systems, unlike the prokaryotic and lower eukaryotic
expression systems, are efficient in producing active mam-
malian proteins due to their post-translational processing
machinery and presence of endogenous levels of binding
partners that may be necessary to stabilise the expressed
protein of interest. In order to achieve a high yield of pro-
tein for analysis, mammalian expression systems tend to
have been based on isolated, high expression stable cell
lines [21]. A disadvantage of this method is the time taken
to establish these stable cell lines. The transient mamma-
lian expression system described here [7] has many of the
benefits but does not suffer from the time constraints of
stable cell line expression systems.
The ability to pre-screen expression vectors to identify
those giving successful protein expression prior to large
scale protein production helps to reduce time, cost and
lends itself to high throughput handling of samples. The
use of pre-screening with adherent cell cultures is well
practiced but there is little mention in the literature of
using suspension cells for pre-screening. Girard et al.,
2001 [22] reported the use of a twelve-well microtiter
plate agitated on a rotational shaker to grow suspension
mammalian cells. They tested intracellular GFP expres-
sion and found similar expression between small scale
cultures and larger cultures grown in spinner flasks or bio-
reactors. Chambers et al., 2004 [23] and Bahia et al., 2005
[13] have both described the use of 24 well blocks for the
growth of insect cells in suspension and the screening of
baculovirus expression constructs. Recently Davies et al.,
2005 [24] described a method for transient transfection of
HEK-293E cells in 24-well blocks with a lipid based trans-
fection reagent and validated this by comparing with
scaled up shake-flask expression for a set of intracellularly
expressed kinases. We describe the use of 24 well blocks
for pre-screening secreted proteins following transient
transfection of HEK-293E cells in suspension using PEI.
This pre-screen method lends itself to the use of liquid
handling robots for dispensing cells and reagents thus
speeding up the process further.
This small scale transient transfection method can yield
on average 10 µg/ml and so could be used in cases where
very small amounts of proteins are sufficient for down-
stream work (e.g. protein micro-arrays) or could be used
as a pre-screen prior to larger scale culture. We found that
cells grown in 2 ml cultures in 24 well blocks mimic cell
growth and viability of cells grown in 50 ml shake cul-
tures. These 2 ml cell cultures were also successfully trans-
fected with expression vectors using PEI in the 24 well
blocks and protein expression profiles matched those of
Determination of dot blot denaturation conditions to use Figure 5
Determination of dot blot denaturation conditions to use. Purified EfnB2-EC in mock supernatant was incubated in 
urea at different concentrations for 1 hour at room temperature prior to loading onto a nitrocellulose membrane in triplicate 
using the dot blot apparatus. After detection of His tagged proteins (see Methods section) with anti-His tag mAb and Cy5 
labelled goat anti-mouse antibody the blots were scanned on a Typhoon 8600 variable mode imager (A) and dots were quanti-
tated using ImageQuant software (B).
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Dot blot calibration curves using three standard proteins Figure 6
Dot blot calibration curves using three standard proteins. Three purified proteins (quantitated by SEC) diluted in mock 
supernatant and denatured by addition of urea to a final concentration of 5 M were analysed within a range of 0 to 3000 ng per 
dot by dot blot. R2 were calculated by linear regression analysis (SigmaPlot, SPSS Inc). Error bars represent standard deviations 
calculated from the data (n = 3).
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Screening expression yield of 24 well cultures by dot blot Figure 7
Screening expression yield of 24 well cultures by dot blot. Supernatants from 2 ml 24 well blocks transient transfec-
tions were analysed by Cy5 dot blot using denaturing conditions of 5 M urea. The top half of the blot represents supernatants 
from cells seeded at 5 × 105 cells/ml and the bottom half of the blot represents supernatants from cells seeded at 1 × 106 cells/
ml. Dots showing secretion positive hits are indicated by a circle (14 positive hits and 9 failures). Those dots corresponding to 
successful purification hits from large scale transient transfections are shown by a square box around the vector number. The 
signal intensity of the dots is shown in table 2. The control protein C was rCD4 (domains 3 + 4)-His10 expressed from vector 
C, Figure 1.
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50 ml transfection cultures. The use of the dot blot
method allows the screening of large numbers of samples
and can be used in conjunction with the 24 deep well
block to allow the screening of 4 × 24 well blocks in par-
allel.
We found that the addition of urea helps immobilisation
of proteins on the membrane. The ability of urea to
unfold proteins and expose hydrophobic amino acids
may make it easier for the proteins to adhere to the mem-
brane and counteract the presence of hydrophilic glyco-
sylated residues that interfere with binding of the protein
to the membrane. E. coli MBP, which is not glycosylated,
did not require urea denaturation for efficient binding to
nitrocellulose (data not shown). The dot-blot method is
semi-quantitative when comparing different proteins due
to the differential binding ability of various proteins to
the membrane. Even when proteins are denatured they
bind to the membrane with differing efficiency. This can
be seen on the dot blot calibration curves where three con-
trol proteins showed binding within a linear range but
each protein bound to the membrane with varying success
(Figure 6). There appears to be no correlation between
efficiency of binding to the membrane and protein size, pI
or number of glycosylation sites. However, the use of the
dot blot method for quantitating multiple different con-
structs (for example containing different truncations of a
single protein when annotated domain boundary infor-
mation is absent) could be very useful and the pre-screen
and dot blot combination is useful for optimising culture
conditions for a single protein.
We found that in almost every case the intensity of dots on
the dot blot correlated to success of proteins being puri-
fied. The notable exception to this was #16, which despite
being strongly positive by dot blot narrowly failed protein
purification by falling below the required 200 µg for peak
collection. The reason for this has not been determined
but might be due to the differential binding of proteins to
the membrane as seen with the standard curves. It may
also be explained by the lack of accessibility of the his-tag
during purification under native conditions. The analysis
of small scale pre-screen cultures is not limited to western
blot and dot blot analysis. Alternative methods to quanti-
tate small scale expression may include bead capture via
the His tag, elution, followed by quantitation of the puri-
fied protein or ELISA based screens.
Conclusion
We have shown that small scale transfection of HEK-293E
cells are a scalable way to produce protein and can be per-
formed in 24 deep well blocks correlating well to what is
seen in larger scale transfections. The use of dot blot
screening of supernatants allows the rapid identification
of vectors or conditions yielding sufficient secreted pro-
tein to proceed successfully through purification when
grown in a larger scale. By identifying failed constructs
early, the approach reduces time, cost and labour of
processing negative experiments at a large scale.
Methods
Construction of C-terminal tagged pTT3 GATEWAY 
destination vectors
The pTT3 vector was digested with PmeI and BamHI to
allow the introduction of a PmeI/BglII digested PCR frag-
ment to create pTT3DestHis10. The PCR fragment con-
sisted of a GATEWAY cassette with 5' PmeI-HindIII and 3'
SfiI-EcoRV-His10-BglII-HindIII flanking regions. The
GATEWAY cassette was amplified from an in house vector
pDest6 using the following forward and reverse primers
respectively. 5':TTATTAGTTTAAACAAGCTTAGGATC-
CCCCATCAAACAAG:3' and 5':TATTATAAGCTTA-
GATCTCGAATTAGTGATGGTGATGGTG:3'. The resulting
pTT3DestHis10 vector contained 5' PmeI-HindIII-GATE-
WAY cassette-SfiI-EcoRV-His10-Bam/Bgl fusion 3'. Vector
pTT3DestHis10 was further modified by addition of a tag,
rCD4 domains 3 and 4, at the SfiI site. The rCD4 tag was
introduced as a 5' DraIII-rCD4-SfiI 3' insert to create
pTT3DestrCD4(d3+4)-His10. The rCD4 tag was obtained
from a vector supplied by Neil Barclay using the following
forward and reverse primers respectively. 5': TACAC-
GAAGTGACATCCATCACGGCCTATAAGAGTG:3' and
5':TAGGCCATTCTGGCCCATTCAACCCTTTGGA-
TAAAACCTGG:3'. Vector pTT3DestSPHis10 was con-
structed by introducing the CD33 signal peptide sequence
into pTT3DestHis10 at the PmeI site as a phosphorylated
blunt linker fragment. The forward and reverse oligos
used are shown respectively:
5':ACCATGCCGCTGCTGCTACTGCTGCCCCTGCTGT-
GGGCAGGGGCCCTGGCTATGGATCA:3'
5':TGATCCATAGCCAGGGCCCCTGCCCACAGCAG-
GGGCAGCAGTAGCAGCAGCGGCATGGT:3'
cDNA isolation and expression vector generation
A nested PCR strategy was used to isolate protein encod-
ing ORFs directly from cDNA [25] and adapted for GATE-
WAY cloning. Briefly 2 sets of primer pairs were designed,
the first pair of optimised primers binding 1 – 200 bp 5'
and 3' of the ORF using in house software and a second
set of forced primers targeted to the beginning (start Met)
and end (5 aa upstream of TM domain) of the ORF. All
primers were designed with melting temperatures around
60°C. PCRs were carried out as described [18] with the
following additions. For entry clones to be transferred to
C-terminal tag expression vectors the PCR-2 forward and
reverse primers used were 5' AAAAAGCAGGCTACC 3'
and 5' AGAAAGCTGGGTT 3' respectively with the for-
ward primer encoding the kozak sequence. The recombi-
national cloning of attB flanked PCR products with anBMC Biotechnology 2006, 6:49 http://www.biomedcentral.com/1472-6750/6/49
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attP containing pDONR vector to generate a set of entry
plasmids was as described previously [18]. The LR recom-
bination reactions using sequence confirmed entry vector
and pTT3 adapted destination vector to generate expres-
sion vectors [18] were used to transform E. coli DH5α
cells (Invitrogen). Vector pTT3DestHis10 was used to gen-
erate the control vector expressing mouse CD4 domains 3
+ 4 (Figure 1A). Vector pTT3DestrCD4(d3+4)-His10 was
used to generate all the test vectors used in this study (Fig-
ure 1B). Vector pTT3DestSPHis10 was used to generate
the control vector expressing rat CD4 domains 3 + 4 (Fig-
ure 1C). A similar vector was used to generate the control
vector expressing mouse EfnB2 except the C-terminal tag
was 8xHis residues rather than 10. Plasmid DNA for use
in transfections of HEK-293E cells was prepared by either
maxi-prep filter kit (Invitrogen) or mini-prep kit (Qia-
gen). DNA was quantitated using the picogreen assay
(Molecular probes).
Cell culture
Suspension adapted HEK-293E cells were originally
obtained from Yves Durocher (Biotechnology Research
Institute, National Research Council Canada, Montreal,
Canada). HEK-293E cells were maintained in FREESTYLE
media (Invitrogen) supplemented with 1 % FBS (Invitro-
gen) and 50 µg/ml G418 (Novagen). Cells were main-
tained in agitated vented Erlenmeyer flasks (Corning) at
120 rpm (orbital throw 25 mm), 37°C, 5 % CO2 and 40
% humidity. Cells were routinely maintained at > 95 %
viability and passaged when the cell density reached 1–4
× 106 cells/ml. For cells grown in 24 well blocks 0.1 %
pluronic (Sigma) was also added. For culture volume
comparison in 24 well blocks, HEK-293E cells were
seeded in 24 well blocks at 0.5 × 106 cells/ml in a total vol-
ume of 2 or 4 ml. Blocks were sealed with an air-pore
membrane and incubated in an Infors Multitron II incu-
bator at 37°C, 5 % CO2, 40 % humidity at 400 rpm. Sam-
ples were analysed every 24 hours over a period of 96
hours for cell growth and viability. For the growth kinetic
studies cells were seeded at 1 × 106 cells/ml in a total vol-
ume of 50 ml (flask) or 2 ml (24 well blocks) and grown
as above.
Transient transfections
Large scale transient transfections were performed where
HEK-293E cells were seeded at 5 × 105 cells/ml in 50 ml
and incubated for 24 hours prior to transfection. When
the density reached approximately 1 × 106 cells/ml the
cells were transfected. In 5 ml of unsupplemented FREE-
STYLE media 25 µg of plasmid DNA was added followed
by 50 µg of the linear cationic polymer polyethylenimine
(PEI) (Polysciences), prepared according to Durocher et
al. [7], the mixture was vortexed, incubated at room tem-
perature for 10 min and added to the cells. Cells were
incubated at 37°C, 5 % CO2, 40 % humidity and agitated
at 120 rpm. Supernatants were harvested 5 days post
transfection (dpt) by centrifugation at 1942 × g, 5 min at
4°C. Protease inhibitor cocktail III (Novagen) was added
to the cleared supernatant prior to storage at 4°C. Small
scale transient transfections were performed where HEK-
293E cells were seeded in 24 well blocks at either 0.5 × 106
cells/ml or 1 × 106 cells/ml in a total volume of 2 ml and
pluronic added to a final concentration of 0.1 %. Cells at
0.5 × 106 cells/ml were transfected with DNA/PEI complex
made by adding 0.5 µg of DNA to 200 µl of unsupple-
mented FREESTYLE media followed by 2 µg of linear PEI
and treated as above. Cells at 1 × 106 cells/ml were trans-
fected as above except 1 µg DNA was used. Blocks were
incubated at 37°C, 5 % CO2, 40 % humidity, 400 rpm
and supernatants were harvested 5 dpt as above.
Western blot analysis
Secreted protein expression was analysed by adding 16.25
µl of supernatant to a 96-well plate containing 6.25 µl of
4 × NuPage LDS loading buffer (Invitrogen) and 2.5 µl of
reducing agent (Invitrogen), the plate heated at 70°C for
10 min and 10 µl loaded onto a 17-well 4 – 12 % NuPAGE
Bis-Tris gel (Invitrogen) using a multi-channel syringe
(Hamilton). A His-tagged molecular weight marker was
run on each gel (Qiagen). Proteins were electro-trans-
ferred onto a 0.45 µM PVDF membrane (Invitrogen).
Membranes were blocked for 1 hr with 3 % low fat dried
milk powder (Marvel) in phosphate buffered saline (PBS)
– 0.1 % tween, incubated for 1 hr with anti-His5 mono-
clonal antibody (Novagen) at 40 ng/ml in 3 % Marvel-
PBS-Tween, washed 3 × in PBS-Tween, incubated with 1
µg/ml of Cy5 labelled goat anti-mouse antibody (Amer-
sham) in 3 % Marvel-PBS-Tween for 1 hr, washed 3× in
PBS-Tween followed by a final wash in water prior to the
blots being dried at 37°C for 10 mins between blotting
paper. The blots were scanned on a Typhoon 8600 varia-
ble mode imager (Amersham) with fluorescence scan
mode, 633 nm excitation laser, 670 nm emission filter,
600 V PMT and 200 µm/pixel scan resolution. The fluores-
cence intensity volumes of bands on the gel were quanti-
tated using ImageQuant TL software (Amersham).
Dot blot analysis
Purified proteins were diluted in mock supernatant prior
to analysis on dot blot. Both purified proteins and test
supernatants were denatured by addition of urea (to a
final concentration of 5 M) at room temperature for 1
hour. Samples (300 µl/well) for dot blot analysis were
loaded onto the Minifold I dot blot apparatus (Schleicher
and Schuell) using a multi-channel pipette (Matrix) and
allowed to adsorb to the protan nitrocellulose membrane
(Whatman) under vacuum. Dot blot membranes were
blocked and probed as described above for the western
blots.BMC Biotechnology 2006, 6:49 http://www.biomedcentral.com/1472-6750/6/49
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Purification of 50 ml culture supernatants
Purification of His tagged proteins was performed using
an AKTA 3D system (GE Healthcare). Supernatants were
pre-conditioned by the addition of 4 M imidazole and 5
M NaCl to give final concentrations of 40 mM and 200
mM respectively. These were left at 4°C for 10 minutes
and then spun at 27,750 g at 4°C for 10 min. The clarified
supernatants were loaded sequentially at 1.5 ml/min onto
five 1 ml Nickel Sepharose columns (GE Healthcare), pre-
equilibrated with 2 × PBS (20 mM phosphate (pH7.4),
300 mM NaCl). The columns were then washed with 9.8
column volumes (CV) 2 × PBS each to remove non-specif-
ically bound material. The second wash of the affinity col-
umns was performed with 20 % B (400 mM imidazole,
500 mM NaCl, 50 mM Bicine pH 8.0) mixed in to increase
the stringency (effectively 80 mM imidazole) of the wash.
The columns were then washed back to 0 % B (2 × PBS)
over 2CV prior to elution by step gradient to 100 % B.
Eluted peaks were collected temporarily into a 5 ml loop
prior to re-injection to a desalting column. The desalting
column (2 × 5 ml HiTrap Desalt GE Healthcare) was pre-
equilibrated with 50 mM sodium acetate, 20 mM NaCl
pH 5.0 to exchange His tagged proteins into the running
buffer of the Resource S cation exchange column (GE
Healthcare) providing the final concentration step. The
protein peak eluted from the desalting column was col-
lected into a 10 ml loop prior to re-injection onto the
Resource S column. Elution from the cation exchange col-
umn was carried out with a step gradient to 50 mM Bicine,
500 mM NaCl, 1.25 mM tris(hydroxypropyl)phosphine
(THP). The protein was eluted in 1 ml and ready for quan-
titation.
Quantitation of purified proteins
Quantitation of the His tagged proteins was done by ana-
lytical size exclusion chromatography (SEC). Proteins
were first centrifuged at 25,000 g for 10 minutes to
remove insoluble aggregates. The Fast Desalt PC3.2/10
(GE Healthcare) column was used directly connected to
the flow cell on the AKTA Purifier 10 system (GE Health-
care) with an Auto-sampler. The column was equilibrated
with 2 × PBS, 10 mM EDTA and run at 0.6 ml/min, 25 µl
of each sample was injected onto the column. The peak
area under the curve was converted to concentration in
microgramme per milliliter using the calculated extinc-
tion coefficient for each protein [20,26].
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